Edition:
United States

Conatus Pharmaceuticals Inc (CNAT.OQ)

CNAT.OQ on NASDAQ Stock Exchange Global Market

1.94USD
9 Dec 2016
Change (% chg)

$0.03 (+1.57%)
Prev Close
$1.91
Open
$1.91
Day's High
$1.96
Day's Low
$1.91
Volume
5,783
Avg. Vol
57,096
52-wk High
$4.04
52-wk Low
$1.41

CNAT.OQ

Chart for CNAT.OQ

About

Conatus Pharmaceuticals Inc. is a biotechnology company. The Company focuses on the development and commercialization of medicines to treat liver disease. The Company operates through commercialization and development of pharmaceutical products segment. The Company is engaged in developing emricasan, which is an orally active... (more)

Overall

Beta: 0.91
Market Cap(Mil.): $50.57
Shares Outstanding(Mil.): 26.07
Dividend: --
Yield (%): --

Financials

  CNAT.OQ Industry Sector
P/E (TTM): -- 41.98 30.40
EPS (TTM): -1.26 -- --
ROI: -75.76 -0.36 15.24
ROE: -78.36 -0.94 16.58

BRIEF-Conatus pharmaceuticals reports Q3 loss per share $0.31

* Q3 earnings per share view $-0.34 -- Thomson Reuters I/B/E/S

Nov 08 2016

BRIEF-Exalenz Bioscience Announces Collaboration with Conatus Pharmaceuticals to Use BreathID to Monitor Patients with Cirrhosis Associated with NASH

* Exalenz Bioscience announces collaboration with Conatus Pharmaceuticals to use BreathID to monitor patients with cirrhosis associated with NASH

Aug 29 2016

BRIEF-Conatus Pharmaceuticals Inc qtrly loss per share $0.30

* Conatus pharmaceuticals reports second quarter 2016 financial results and program updates

Aug 03 2016

BRIEF-Conatus says Louis Lacasse resigned from the board of directors

* Says on June 23, 2016, Louis Lacasse resigned from the board of directors- SEC filing

Jun 24 2016

Competitors

  Price Chg
BASF SE (BASFn.DE) €85.38 -0.34
Johnson & Johnson (JNJ.N) $112.26 +1.27
Novartis AG (NOVN.S) CHF70.75 +2.25
Merck & Co., Inc. (MRK.N) $61.23 +1.11
Roche Holding Ltd. (ROG.S) CHF227.80 +7.40
Roche Holding Ltd. (RO.S) CHF231.00 +4.90

Earnings vs. Estimates